Trulieve Cannabis Corp.'s next confirmed earnings release is scheduled for November 5, 2026.
| Earnings Date | 11/5/2026 |
As of June 30, 2026, Trulieve Cannabis Corp. has 192.38M shares outstanding.
| Shares Outstanding | 192.38M |
As of June 30, 2026, Trulieve Cannabis Corp. maintains a current ratio of 5.94, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 75.37, indicating elevated leverage, while an interest coverage ratio of -1.89 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.94 |
| Quick Ratio | 3.71 |
| Debt / Equity | 75.37 |
| Debt / EBITDA | -5.38 |
| Interest Coverage | -1.89 |
Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. posted a negative return on equity (ROE) of -47.51, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -18.93, reflecting losses generated across the asset base. The company generates approximately 189,905.09 in revenue per employee across its workforce of 5,250.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.16 indicates how many times Trulieve Cannabis Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -47.51 |
| Return on Assets (ROA) | -18.93 |
| Revenue Per Employee | 189,905.09 |
| Employee Count | 5,250.00 |
| Inventory Turnover | 2.16 |
Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. recorded 126.70M in income tax expense. The company reported a pretax loss of -285.29M and -414.28M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 126.70M |
Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. generated 997.00M in revenue and converted that into -414.28M in net income, yielding earnings per share of -2.13. EBITDA reached -93.93M, while operating income came in at 114.72M.
| Revenue | 997.00M |
| Gross Profit | 592.92M |
| Operating Income | 114.72M |
| Pretax Income | -285.29M |
| Net Income | -414.28M |
| EBITDA | -93.93M |
| EBIT | -242.69M |
| Earnings Per Share (EPS) | -2.13 |
As of June 30, 2026, Trulieve Cannabis Corp. holds 284.84M in cash and equivalents against 505.28M in total debt, resulting in a net debt position of -31.54M. Total book value stands at 671.76M, with working capital of 411.19M providing operational flexibility.
| Cash & Cash Equivalents | 284.84M |
| Total Debt | 505.28M |
| Net Debt | -31.54M |
| Equity (Book Value) | 671.76M |
| Book Value Per Share | 3.49 |
| Working Capital | 411.19M |
Trulieve Cannabis Corp. produced 213.96M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -20.57M in capital expenditures, free cash flow totaled 193.39M - equivalent to 1.01 per share.
| Operating Cash Flow | 213.96M |
| Capital Expenditures | -20.57M |
| Free Cash Flow | 193.39M |
| FCF Per Share | 1.01 |
Over the twelve months ended June 30, 2026, Trulieve Cannabis Corp. posted a gross margin of 59.47, reflecting its pricing power and cost economics. The operating margin of 11.51 and net profit margin of -41.55 provide insight into operational efficiency.
| Gross Margin | 59.47 |
| Operating Margin | 11.51 |
| Pretax Margin | -28.61 |
| Profit Margin | -41.55 |
| EBITDA Margin | -9.42 |